학술논문

A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain
Document Type
Article
Source
In: Expert Review of Pharmacoeconomics and Outcomes Research. (Expert Review of Pharmacoeconomics and Outcomes Research, 2024, 24(2):227-235)
Subject
Language
English
ISSN
17448379
14737167